Spastazoline Protocol: Handling, Storage & Assay Guidelines

Spastazoline is a research-grade small-molecule compound (Aladdin SKU S412554; Selleck S0801) requiring careful reconstitution, defined storage conditions, and controlled assay conditions to ensure experimental reproducibility and data integrity.

Product Name

Spastazoline

Aladdin SKU

S412554

Selleck Number

S0801

Recommended Use

In vitro research assays; refer to current literature for confirmed biological targets

Stock Solution Preparation

Dissolve in DMSO to prepare a concentrated stock; exact solubility should be verified experimentally

Storage Condition

-20 °C, desiccated and protected from light (recommended best practice for small molecules)

Materials and Equipment

Before beginning, assemble the following materials:

• Spastazoline (Aladdin S412554 / Selleck S0801), supplied as a solid
• Anhydrous DMSO (cell-culture grade) for stock solution preparation
• Analytical balance capable of weighing milligram quantities
• Calibrated micropipettes and low-retention tips
• Amber or foil-wrapped microcentrifuge tubes to protect from light
• Vortex mixer and brief-centrifuge
• Biological safety cabinet (if working with live cells)
• Personal protective equipment: lab coat, chemical-resistant gloves, safety glasses

Note: Confirm the molecular weight and purity from the certificate of analysis (CoA) supplied with each lot before preparing working solutions.

Stock Solution Preparation and Storage

Follow these steps to prepare a stock solution of Spastazoline:

1. Equilibrate to room temperature: Allow the sealed vial to warm to ambient temperature before opening to prevent moisture condensation on the powder.
2. Weigh the compound: Tare the microcentrifuge tube and transfer the required mass of Spastazoline. Record the exact mass from the CoA-confirmed quantity.
3. Add DMSO: Add anhydrous DMSO to achieve the desired stock concentration (e.g., 10 mM). Calculate the volume using: V (µL) = [mass (mg) / MW (g/mol)] × 10⁶ / target concentration (mM).
4. Vortex and centrifuge: Vortex for 30–60 seconds, then briefly centrifuge (2000 × g, 10 s) to collect solution at the tube bottom. Verify complete dissolution visually.
5. Aliquot: Prepare single-use aliquots in amber tubes to minimize freeze–thaw cycles and light exposure.
6. Store at −20 °C, desiccated and protected from light. Avoid storing in frost-free freezers that cycle temperature. Consult the CoA for lot-specific stability data.

Working dilutions should be prepared fresh in cell culture medium immediately before use. Ensure the final DMSO concentration in assay wells does not exceed 0.1% (v/v) unless validated otherwise for your cell system.

Cell-Based Assay Setup

The following general procedure applies to in vitro cell-based assays using Spastazoline. Optimise all parameters for your specific cell line and endpoint.

1. Cell seeding: Seed cells at an appropriate density 18–24 hours before compound treatment to ensure sub-confluent, actively dividing monolayers at time of dosing.
2. Prepare dilution series: Prepare a serial dilution of Spastazoline from the DMSO stock in assay medium to achieve the desired concentration range. Include a vehicle control (DMSO at matched concentration) and a positive control if available.
3. Treat cells: Replace medium with compound-containing medium and incubate under standard culture conditions (37 °C, 5% CO₂) for the desired treatment duration.
4. Endpoint measurement: Perform the relevant assay (e.g., viability, target engagement, or pathway reporter assay) according to validated protocols for your readout.
5. Data analysis: Normalise readouts to vehicle control. Calculate IC₅₀ or EC₅₀ values using non-linear regression with appropriate curve-fitting software.

Important: Specific concentration ranges, incubation times, and biological endpoints for Spastazoline should be determined from peer-reviewed literature and validated in your laboratory system.

Safety and Waste Disposal

Spastazoline is supplied for research use only and is not approved for human or veterinary use. Treat as a potential hazard until full toxicological characterisation is available.

• Personal protection: Wear appropriate PPE at all times: chemical-resistant gloves, lab coat, and safety glasses.
• Inhalation risk: Handle powders and volatile solutions in a ventilated fume hood or biological safety cabinet to avoid inhalation of aerosols or dust.
• Skin/eye contact: In case of contact, rinse immediately with copious water and seek medical advice if irritation persists.
• DMSO penetration: Note that DMSO can enhance skin penetration of dissolved compounds; double-glove when handling DMSO stock solutions.
• Waste disposal: Dispose of compound-containing solutions, tips, and tubes as chemical waste in accordance with your institution's environmental health and safety (EHS) regulations and local government ordinances.

Consult the Safety Data Sheet (SDS) for Spastazoline prior to use. Contact Aladdin Scientific for the current SDS if not supplied with your order.

Frequently asked questions

What solvent should I use to dissolve Spastazoline?

Anhydrous DMSO is the recommended primary solvent for preparing Spastazoline stock solutions. Aqueous solubility and compatibility with other solvents should be verified experimentally, as solubility data specific to this compound were not available in the source material.

How should Spastazoline be stored to maintain stability?

Store Spastazoline at −20 °C in a desiccated, dark environment. Aliquot stock solutions to minimise freeze–thaw cycles. Always consult the certificate of analysis (CoA) for lot-specific stability and expiry information, as general guidance may not reflect compound-specific data.

What is the maximum DMSO concentration acceptable in cell-based assays?

As a general best practice, the final DMSO concentration in assay wells should not exceed 0.1% (v/v) to avoid cytotoxic effects. However, this threshold may vary by cell type and should be validated empirically with appropriate vehicle controls in your specific experimental system.

Is Spastazoline the same as Selleck compound S0801?

Yes. Aladdin Scientific SKU S412554 (Spastazoline) corresponds to Selleck catalog number S0801. Researchers cross-referencing literature or protocols using the Selleck designation S0801 can use this product accordingly, subject to lot-specific CoA verification.

References

1. Selleck Chemicals. Spastazoline (S0801) product information. Selleck Chemicals LLC.
2. Aladdin Scientific. Spastazoline (S412554) product page. Aladdin Scientific.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.